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ABSTRACT 
 
 
Pregnane X receptor (PXR) is a ligand-activated nuclear receptor that regulates 
gene expression of the metabolizing enzymes that are involved in detoxification of 
endogenous and exogenous compounds in the gastrointestinal (GI) tract.  In recent years, 
PXR has been found to have novel functions in maintenance of homeostasis of the GI 
tract, as mice deficient in PXR have spontaneous intestinal inflammation.  Because the 
GI tract homeostasis is maintained through interactions between microbiota and host 
intestinal cells, we investigated the role of PXR in regulating the susceptibility of the 
colon cells to Salmonella infection.  Using PXR-transfected HCT116 and HT29 cell 
lines we found that PXR transfected cells were resistant to the Salmonella infection and 
the resistance was dependent on the PXR activation by the typical PXR agonists 
rifampicin (RIF) and hyperforin.  Furthermore, the ligand-dependent resistance could be 
antagonized by the PXR antagonist ketoconazole, confirming the role of PXR in 
resistance.  In an earlier study, we found NF-κB activation by LPS to inhibit PXR 
activity, and, consistent with the observation, LPS treatment of the cells weakened the 
resistance of the PXR-transfected cells to Salmonella infection.  To understand the 
mechanism of the PXR-regulated resistance, we analyzed the role of PXR in regulating 
the intestinal barrier gene expressions such as occludin, ZO-1, and claudin, and found 
that occludin expression was significantly up-regulated by the PXR activation.  Taken 
together, our results suggest that PXR plays a role in regulating GI tract resistance to 
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pathogenic bacterial infection and provides a potential therapeutic approach for 
treatment of Salmonella infection.  
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NOMENCLATURE 
 
PXR Pregnane X Receptor 
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HR Hormone Receptor 
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PAH Polycyclic Aromatic Hydrocarbon 
BaP Benzo[a]pyrene 
LCA Lithocholic Acid 
RIF Rifampicin 
TCM Traditional Chinese Medicine 
XREM Xenobiotic Response Element 
LPS Lipopolysaccharide 
TLR Toll-like Receptor 
IPA 3-propionic Acid 
T3SS Type 3 Secretion System 
SPI-1 Salmonella Pathogenicity Island-1 
FBS Fetal Bovine Serum 
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CFU Colony Forming Unit 
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1. INTRODUCTION 
The interaction between gene and environment is an important force 
continuously governing the genotypes and phenotypes of organisms.  To deal with the 
unavoidable exposure to the xenobiotics in surrounding environment, animals have 
developed an efficient defense system consisted of the so-called xenobiotic receptors, 
such as pregnane X receptor (PXR, also known as the steroid and xenobiotic receptor, 
SXR) and constitutive androstane receptor (CAR).  These become parts of the "chemical 
defense";  If faced with infectious agents, organisms display innate and adaptive immune 
response, that the nuclear factor-κB (NF-κB) is the most important regulator in it.  
Collectively, these consist the parts of the “biological defense” mechanisms.  These two 
arms of the defense systems are critical for the survival and evolutionary success of the 
organism.  In recent years, increasing evidence suggests that these two systems are 
integrated to govern the wellbeing of the organisms and their crosstalk is found the to be 
the underpinning mechanism for some diseases such as the inflammatory bowel disease 
(IBD), adverse drug-drug interactions (ADIs).  Modulation of the crosstalk through 
therapeutic drugs has been shown to be effective in treating the IBD.  My research 
explores the role of PXR in controlling the mechanism of defense against the bacterial 
infections in cell culture model. 
 
1.1 Xenobiotic receptors and their roles in metabolic detoxification 
Xenobiotics (foreign compounds) are generally referred to as the compounds or 
substances that are normally not present in the organisms.  The xenobiotic compounds 
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may be produced synthetically or generated naturally such as the plant and microbial 
metabolites, animal excretions, environmental pollutants, pesticides, industrial chemicals, 
and therapeutic drugs.  They are an unavoidable part of our everyday life.   
In order to survive, the organisms need to interact with their environment and this 
requires an efficient system to deal with the harmful xenobiotics.  In animals, this 
defense network consists of the xenobiotic detoxification system.  This system includes 
the phase I and phase II metabolizing enzymes, which PXR is involved in by regulating 
some important enzymes, such as cytochrome P450 (CYP) 3A4.  
Phase I reactions are catalyzed by the monooxygnase enzymes such as 
cytochromes P450 that modified the molecules to be more polar and more susceptible to 
phase II reactions.  Phase II conjugating reactions conjugated xenobiotics with charged 
species such as glutathione (GSH).  Phase II reactions are to increase molecular weight 
and add large anionic groups (GSH) that they cannot passively diffuse through 
membranes and in favor of xenobiotic detoxification and excretion. 
Among the three well-known xenobiotic receptors, aryl hydrocarbon receptor 
(AhR) is a bHLH-PAS transcription factor sharing no DNA sequence homology with the 
classic nuclear receptor.  Its transcriptional functions require an obligatory partner 
ARNT.  Once ligand activated, the AhR-ARNT complex interacts with the consensus 
DNA sequences bearing the conserved core motif (GCGTG), which is often found in the 
regulatory regions of the genes such as the cyp1a1, cyp1a2 and cyp1b1.  CAR is unique 
among the nuclear receptors in that its transcriptional action is constitutively activated 
even without ligand existed.  PXR on the other hand is a bona fide nuclear receptor, 
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which is a ligand-dependent transcriptional regulator to regulate physiological functions 
involved in the xenobiotic metabolism.  PXR is a unique xenobiotic receptor with its 
large and flexible ligand-binding pocket that enables it to bind to various structurally 
different xenobiotics.  The known xenobiotics that interact with PXR include over 60% 
of clinical drugs, environmental pollutants, herbs, and microbiota metabolites, et al.  In 
addition to its well characterized role in regulating xenobiotic metabolism, in recent 
years, it has been found that PXR plays an important role in the regulation of various 
physiological and pathophysiological processes such as the IBD, lipid and glucose 
metabolisms.    
 
1.2 Xenobiotic receptor PXR belongs to nuclear receptor superfamily 
Since the publication about researching the cloning of the first nuclear receptor-
human glucocorticoid receptor (GR) in 1985[1], there has been significant progresses 
made in this field.  
Nuclear receptor superfamily has abundant types of transcriptional regulation 
factors in animals.  Many nuclear receptors act as ligand-regulated transcriptional 
regulators, and thereby connect directly between signal transduction molecules and 
transcription responses.  This superfamily consists of receptors, such as PXR, thyroid 
hormone receptor (TR), retinoid acid receptor (RAR), vitamin D receptor (VDR) for 
regulating hydrophobic molecules like steroid hormone, thyroid hormone, retinoic acid, 
fatty acid, leukotriene, prostaglandins as well as lipophilic xenobiotics[2]. 
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1.2.1 Classic structure of nuclear receptor 
In terms of nuclear receptor structure, molecules like PXR, CAR and RXRα 
share common structural traits.  Most of nuclear receptors include an N terminal ligand 
independent activation function 1 (AF-1), a highly conserved double zink-finger DNA 
binding domain (DBD), a large ligand binding domain (LBD) and a ligand dependent 
activation function 2 (AF-2) region at the C terminal.  Nuclear receptor superfamily is 
usually categorized as steroid receptors, with estrogen receptor (ER) being the most 
investigated, orphan receptors and adopted orphan receptors such as PXR and LXR.  
Steroid receptors are to sense the existence of steroid hormones and act as homodimers, 
whereas adopted orphan receptors act as heterodimer complexes with the common 
nuclear receptor partner-retinoid X receptor α (RXRα).  As shown in Figure 1, is the 
most common structure of nuclear receptor in the examples of RXR, CAR and PXRα.  
However, there are many exceptions of nuclear receptors that do not follow 
classic nuclear receptor structure domains.  For example, there are receptors that lack of 
DBD, such as short heterodimer partner (SHP).  Our research target PXR is unique in the 
nuclear receptors for its larger and more flexible ligand binding pocket, making it able to 
sense a much wider range of the ligands than other nuclear receptors[3].  
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Figure 1. Functional and structural domains of PXR, CAR and RXRα as examples of 
nuclear receptors (A/B as AF-1, C as DBD, E/F as LBD and AF-2)[4] 
 
1.2.2 Mode of action of nuclear receptors 
Ligand-activated nuclear receptors share many common features in the mode of 
action.  Certain nuclear receptors such as the progesterone receptor (PR), CAR are found 
in the cytoplasm and their nuclear translations are triggered by the ligands which are 
typically hydrophobic small molecules that transverse the cellular membrane by passive 
diffusion.  After passing through the cytoplasmic membrane, the ligands interact with 
the nuclear receptor causing conformational changes of the receptors and releasing of the 
accessary proteins factors such as the heat shock proteins.  Interaction with ligands 
seems to enhance the nuclear receptor accumulation.  Interestingly, PXR has been found 
in both cytoplasm and nucleus.  The cytoplasmic function of the PXR, however, is 
unknown, under investigation in our laboratory.  Some receptors such as the ER has 
been reported to have "non-genomic” effects through regulation of no-receptor tyrosine 
kinases and some cell membrane proteins.   
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In the classic view of the nuclear receptors in the absence of agonist, the 
chromatin bound receptor interacts with a co-repressor complex typically containing the 
histone deacetylased (HDAC) at the regulatory region.  Upon the agonist binding, the 
AF-2 region dissociates the co-repressor protein and recruits the transcriptional co-
activator complexes typically containing histone acetyltransferases (HATs) as well as 
the mediator complexes, which in turn promote the gene expression regulated by the 
recruitment of the basal transcription machinery (Figure 2).  
 
Figure 2. Transcriptional modulation of nuclear receptors 
 
1.3 Discovery and cloning of PXR 
It has been a long-standing observation that drugs such as glucocorticoid and 
phenobarbital induce liver enzymes such as the cytochrome P450, and the cellular 
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binding entity has been implicated.  Searching for this binding entity and molecular 
characterization of these binding components is important for drug development and 
application.  It was not till 1998, the PXR has been finally identified and characterized of 
the receptor at molecular level, that was made possible through the cloning and sequence 
identification[5, 6].  Characterization of this vital xenobiotic receptor has greatly 
facilitated analyzing the mechanism of the regulation of several important drug 
metabolizing enzymes (DMEs) and transporters.  The constructions of PXR null, PXR 
over expressed and “humanized” PXR models have greatly facilitated the investigation 
of novel functions of PXR, including its regulation of innate immunity in gastrointestinal 
(GI) tract[7] and the maintenance of homeostasis.  In addition, the cloning of the PXR 
made it possible to perform high throughput screening of the drug/xenobiotic for 
determination of their metabolism in the body.   
 
1.4 Mode of action of the PXR regulation of gene cyp3a4 
The mechanism of PXR regulating the gene expression involved several basic 
steps including binding of PXR to the ligands, nuclear translocation, association with the 
conserved DNA sequences (enhancer), and interaction with the co-regulators.  The best-
studied system is its transcriptional regulation of the cytochrome P450 (CYP) 3A4[8]. 
For adult human, CYP3A4 is a main DME in the body, because it predominantly 
expresses in liver and gut where most detoxifications take place, and also because it has 
a variety of substrates including clinical drugs and many endogenous substances.  
Regardless of the non-genetic influencing factors, the genetic effects on CYP3A4 
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expression are reported to be involved in the metabolism of over 60% of drug.  The 
cytochrome P450 such as CYP3A4 regulated by PXR have been found to be highly 
polymorphic which may be important in causing the variations of the individual drug 
metabolism abilities.  These variations are important for rational drug design and 
judicious application of the drugs.   
The gene expression of the cyp3a4 is mainly regulated by PXR, although the 
cross regulation between PXR and CAR has been found[9].  PXR/cyp3a4 gene has been a 
prototypical regulatory model for the analysis of the mode of PXR transcription action, 
as shown in Figure 3. 
Like most other nuclear receptors, after sensing the existence of agonists, PXR 
translocates into nucleus and acts with the common nuclear receptor partner, RXR α.  
The heterodimer complex can recruit several co-activators to bind at the XREM region, 
which is a regulatory region that can regulate the expression and translation, located 
upstream of the cyp3a4 gene.  Because of the wide range of the involvement of the PXR 
in both xenobiotic chemicals and endobiotic subtracts metabolisms, it is critical to 
understand the ligand-dependent gene regulation of PXR and its application in drug 
development and its clinical problems.  
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Figure 3. Mechanism of PXR action 
 
1.4.1 The regulatory role of PXR in xenobiotic metabolism  
 Recently naturally occurring substances/compounds that interact with the PXR 
have evoked a great deal of interests.  For example, the St John’s Wort (SJW) has long 
been applied as an efficient anti-inflammatory and anti-depressant drug.  Despite its 
effective role in the treatment of depressant, it has been found to causes drug-drug 
interactions (DDIs) that if using together with cyclosporine leads to enhanced 
metabolism and clearance of cyclosporine, and trigger adverse interactions with anti-
HIV and anti-inflammatory agents if co-administered with them.  Also, the indole 
metabolites derived from commensal microbiota such as indole 3-propionic acid (IPA) 
has been found as a PXR ligand, suggesting the involvement of PXR in microbiota 
metabolism which in turn may have important implications in drug metabolism and 
DDIs.    
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Another example indicating the importance of PXR in regulating xenobiotics is 
its interaction with polycyclic aromatic hydrocarbons (PAHs).  PAHs are important 
environmental pollutants mainly deposited in fossil fuels and released when there is 
insufficient oxygen for complete combustion.  Benzo[a]pyrene (BaP) is a well known 
PAH that is highly mutagenic and carcinogenic by forming DNA adduct, which is either 
detoxified or activated to its toxic metabolites in body.  It has been reported that BaP is 
capable of the activating of CYP3A4 promoter via PXR[10].  Consistent with this 
observation, research from our laboratory has shown that PXR plays an important role in 
reducing the BaP-induced DNA damages[11].  In addition, our laboratory has found that 
PXR interaction with the AhR pathway through transrepression thereby reducing BaP-
induced DNA damages (manuscript under review).  Therefore, PXR is very important in 
regulating the metabolism of BaP that in favor of its detoxification pathway.  The main 
virulence of BaP in inducing human cancer is its activation by phase I metabolizing 
enzymes mainly consisted of cytochrome P450 (CYP).  After BaP is bioactivated to its 
genotoxic metabolites, it can react with the nucleophilic sites of DNA and form DNA 
adduct, which leads to mutation and cancer.  However, the phase I metabolizing enzyme 
in this toxic activation pathway is also involved in the detoxification by PXR, which 
induces phase I/II metabolizing enzymes and transporters that in favor of the 
detoxification and excretion of BaP, and thus protects human body from BaP-induced 
DNA damage[11].  
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1.4.2 The regulatory role of PXR in endobiotics metabolism 
Although PXR is identified as an important xenobiotic receptor, its functions in 
regulating endobiotics and maintaining homeostasis are equally important because it also 
senses and responses to various endogenous chemicals.   
One family of PXR endogenous ligands is bile acid and its metabolites.  Bile acid 
is cholesterol metabolite, which is structurally important in bile and lipid.  Whereas, they 
are potential toxins in exceed dose, such as lithocholic acid (LCA), which is the 
secondary bile acid, is the cause of cholestasis.  It is found that PXR can sense and 
detoxify LCA and thus protect from LCA-induced liver damage in experimental mice.  
Since experiments have proved that activated PXR is efficient in the treatment of 
cholestasis, PXR agonists such as rifampicin (RIF) and SJW have been successfully 
used as clinical drugs for cholestasis treatment[12].   
In recent research, PXR has been found an important role in maintaining 
hormonal homeostasis and endocrine system integrity.  PXR, also named as steroid and 
xenobiotic receptor, can sense and regulate the metabolism of hormones, especially 
steroid hormone, which is a regulator of various physiological activities.  As it is shown 
in mice that genetic modified PXR (VP-PXR clone cells) and ligand-dependent activated 
PXR (RIF) have higher rates to activate steroidogenic enzymes to regulate steroid 
hormones.  However, hormonal balance can be easily disrupted by xenobiotics like 
toxins and drugs introduced into the body, because these xenobiotics can induce DMEs 
and transporters that can imbalance homostasis.  Because PXR acts a role as a “sensor 
and effector” in regulating DMEs and DDIs through its transcriptional regulation of 
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various DMEs and drug transporters coordinately[13], it functions as a regulator to 
maintain hormonal balance. 
 
1.4.3 PXR involved in drug-drug interactions 
PXR can be induced through a variety of ligands.  Activated PXR contributes to 
the action of phase I/II DMEs that recognize many gene-involving drugs and substrates, 
that one concern about PXR-targeted drugs is their involvements in DDIs.  RIF 
identified as an effective hPXR agonist, provides an explanation of why RIF is a PXR 
inducer to regulate DMEs, and RIF causes DDI in clinical use.  PXR clinical activation 
drugs also include paclitaxel (Taxol®), the most widely used anti-tumor medicine, 
which is subjected to liver CYP3A4 and CYP2C8 metabolic inactivation.  Besides 
inactivated by liver enzyme CYP450, paclitaxel can be output from intestine through the 
activation of PXR regulated gene (MDR1) that encodes a broad specificity proteins in 
intestinal efflux pump excretion system[12]. 
In addition, some traditional Chinese medicines (TCMs) are found involved in 
DDI.  The biggest concern of herbal products used as clinical drugs is their side effects 
introduced when co-administered with other drugs.  It is been found that two TCMs, Gan 
Cao (Glycyrrhiza uralensis Fisch) and Wu Wei Zi (Schisandra chinensis Baill) can 
induce PXR activity, and regulate various DMEs and transporters activations.  After co-
treated rat with Wu Wei Zi or Gan Cao and warfarin, which is an anticoagulant to 
metabolize CYP2C9, rats showed an up-regulated metabolism rate of the herbal 
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medicine, strengthening security defense involved in using herbs and other nutritional 
supplements in order to prevent PXR-mediated DDIs[12]. 
 
1.5 Physiological functions of PXR in intestine 
PXR is a ligand-dependent transcription factor capable of regulating gene 
expressions that are important for xenobiotic metabolism.  Besides its function as 
xenobiotic sensor and regulator, a novel function of PXR has been uncovered in 
maintaining the homeostasis of GI tract, since it has been shown that mice deficient in 
PXR developed IBDs, and there are intriguing interactions between PXR and intestinal 
barrier functions and commensal microbiota mediated by the microbial derived indole 
metabolites, such as IPA[7].  But in the PXR null mice, the proteins that are important for 
the barrier functions are down-regulated[7]. 
Since PXR mainly presents in liver and other parts of GI tract, its functions in 
xenobiotic detoxification and homeostasis maintaining are involved in many human 
diseases in liver and intestine[14], showing a promising future for PXR ligands 
application.  
 
1.5.1 The anti-inflammatory functions of PXR 
Xenobiotic receptors consist a chemical defense network to sense and detoxify 
xenobiotic chemicals and endobiotic subtracts, and the immune system conducts a 
biological defense.  These two defense systems work independently but indispensable to 
each other.  Coordinately, they provide a survival necessity for the wellbeing of 
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organisms[15].  Our laboratory has reported the interaction between PXR and nuclear 
factor (NF)-κB pathway, which is an important mediator in regulating the adaptive as 
well as the innate immune response[16].  We have observed that the activation of NF-κB 
by lipopolysaccharide (LPS) and tumor necrosis factor (TNF-α) resulted in the 
repression of PXR transcriptional activity[3].  It is reported that LPS signals through toll-
like receptors (TLRs) to induce NF-κB inflammatory cytokines secretion in sepsis[17] 
and suppress the PXR activity, as shown in Figure 4.   
Furthermore, PXR and NF-κB interaction is recently discovered to treat human 
inflammatory disease such as IBD, a chronic inflammation in GI tract.  RIF as a typical 
human PXR agonist, has long been used as a immunosuppressant in suppressing 
immune response, and PXR is discovered to associate with the susceptibility to IBD in 
recent papers, since pregnenolone 16α-carbonitrile (PCN), a PXR agonist in mice, is 
found to protect against IBD in PXR expressed mice but has no protective function in 
PXR null mice.  
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Figure 4. The mutual suppression between PXR and NF-κB 
 
Base on these observations, we reasoned that the inflammation will cause cell 
susceptible to bacterial invasion because the mutual suppressive interaction of LPS and 
PXR.  And we investigated this interaction by measuring the intercellular bacterial 
colony forming unit after co-treatment of LPS and PXR agonists.  
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1.5.2 PXR regulation of innate immunity 
One of the recently discovered functions of the PXR besides its detoxification 
function is its ability to regulate innate immunity.  For example, it has been found that 
PXR is of vital importance in protecting gastrointestinal organs from inflammatory 
responses induced by the harmful commensal microorganisms.  In PXR knockout mice 
model, there are spontaneous inflammatory responses.   
It has been found that PXR null mice developed spontaneous GI tract 
inflammation, suggesting that the importance of PXR in maintaining the homeostasis 
between commensal bacteria and host cells have been observed.  In addition, the indole 
metabolites IPA derived from commensal microbiota serves as a PXR ligand in vivo, 
and it up-regulated mRNA expression encoded for tight junction protein.  The 
microbiota metabolites by-product serves as a PXR ligand indicating an intricate 
interaction between bacteria and host cells.  In this study, we proposed to 
mechanistically test the role of PXR in regulating bacterial resistance in the cultured 
colon cells.  
 
1.6 Salmonella Typhimurium 
Salmonella Typhimurium is an invasive pathogen that infects host cells through 
oral ingestion of contaminated food and water[18].  Salmonella Typhimurium is a very 
common food-borne infection and a major public health problem that causes severe 
diarrhea worldwide.  Salmonella induced gastrointestinal infection is called 
salmonellosis[19].  Each year, Salmonella is estimated to cause nearly one million 
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illnesses in USA alone, including 20,000 hospitalizations and 400 deaths[20].  Symptoms 
after Salmonella infection including diarrhea, fever, headache and abdominal cramps 
after 12 to 72 hours of exposure of contaminated food or water. 
Foodborne pathogens entering through the GI tract can confront several 
differences in the host environment, including pH, salt stress and enzymes differences.  
Generally, acid environment and bile acid inside GI track induce antimicrobial activity 
to fight against pathogenic bacterial infection.  Diarrhoeal pathogens have developed 
several mechanisms to conquer the differences and inhospitalities of the host 
environment.  
 
1.6.1 Mechanism of Salmonella Typhimurium invasion 
Salmonella is a powerful pathogen that has developed several effective strategies 
to infect through the GI tract.  Center of the critical virulence for Salmonella is the type 
3 secretion system (T3SS) (Figure 5) encoded by the Salmonella pathogenicity island-1 
(SPI-1).  T3SSs are protein complexes that are responsible to translocate certain proteins 
directly from bacteria into the host cells.  Upon contacting the surface of the host cells, 
the T3SS secret system is activated and secrets at least 12 effectors inside of the host 
cells that will mediate host cell signaling.  These effectors cause membrane ruffling, 
bacterial invasion and tight junction disruption, although the specific functions of each 
effector are not identified yet[18].  Membrane ruffling and tight junction disruption finally 
lead to bacteria invades inside of host cells and the concomitant nuclear responses lead 
to the secretion of pro-inflammatory cytokines[21].  
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T3SS secretory system in bacteria is functioned as a protein complex that spans 
both inner and outer membranes.  Additionally, there are components in cytoplasm that 
are involved in other steps of effectors secretion process including production of energy, 
protection of the exported protein and regulation of the bacterial invasion or secretion 
processes[21].  
It has reported that T3SS effectors disrupt tight junction both directly and 
indirectly.  Tight junction is located at the interface between intestinal epithelial cells 
including transmembrane proteins, such as claudin and occludin, which establish 
hemophilic interactions between adjacent epithelial cells, and plaque proteins including 
ZO-1 to adapt at the surface of the tight junction.  Many diarrhoeal pathogens invade the 
epithelial barrier of the host cell by disrupting tight junction.  For example, Escherichia 
coli (E.coli) disrupts the host cell barrier by dissociating occludin from tight junction 
area, and Vibrio cholera directly degrade the extracellular domain of occludin[18].  As for 
Salmonella, the expression of occludin is decreased after bacterial invasion[19].  In terms 
of infection symptoms, the break down of tight junction is believed to result in diarrhea 
and other important intestinal inflammation (e.g., IBD)[22].  The mechanism via T3SS of 
diarrhoeal pathogens infection is shown in Figure 6. 
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Figure 5. The type 3 secretion system[21] 
 
 
Figure 6. The mechanism via T3SS of diarrhoeal pathogens infection 
 
1.6.2 Resistance to Salmonella Typhimurium invasion 
An intact intestinal epithelial tight junction barrier acts as a physical block from 
the outside compounds to the internal environment[23].  
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Intestinal epithelial cells are connected by intercellular junction complexes that 
regulate several characteristics such as membrane polarity, integrity, and cell signaling 
ability.  Salmonella is able to invade and replicate in the intestinal cells during infection.  
As expected, the ability of Salmonella to invade the epithelial cells constitutes a key step 
in the pathogenesis.  As mentioned above, an important mechanism in host-bacteria 
interactions can be discovered by studying effectors that interrupt the function of tight 
junction[24]. 
 It has been found PXR null mice developed spontaneous GI tract inflammation 
suggesting that the PXR is of vital importance in the maintenance of homeostasis 
between commensal bacteria and host cells.  So, we investigated the regulation of PXR 
in the resistance to Salmonella infection via regulating the expression of tight junction 
proteins.   
 
1.7 Objectives of my thesis research 
One of the recently discovered functions of the PXR is its ability to regulate 
innate immunity.  For example, it has been found that PXR is of vital importance in 
protecting gastrointestinal organs from inflammatory responses induced by the harmful 
commensal microorganisms.  In PXR knockout mice model, there are spontaneous 
inflammatory responses in GI tract, suggesting that the importance of PXR in 
maintaining the homeostasis between commensal bacteria and host cells have been 
observed.  However, it is not clear whether PXR plays a role in regulating the cellular 
resistance directly without the involvement of immune system.  In this study, we 
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proposed to mechanistically test the role of PXR in regulating bacterial resistance in the 
cultured colon cell lines with modifications of the levels of PXR expression.   
To investigate the role of PXR in regulating the Salmonella infection, we 
utilized the PXR-transfected colon cell lines in the bacterial infection assay and we 
found that PXP plays a critical protective role against Salmonella infection.  We have 
found in an earlier study that bacterial endotoxin LPS inhibited the PXR activity, and we 
tested the effects of LPS of the PXR transfected cell lines and found the resistance was 
weakened after the cells were treated with LPS suggesting the interaction between 
bacterial endotoxin play a role in enhancing the infectivity of the Salmonella through at 
least in part by suppressing the PXR transcriptional activity.    
Because it has been found that adopted orphan nuclear receptors are able to 
signaling regulate certain interactions between bacterial metabolites and host cells.  For 
example, AhR can regulate dietary ligands, and PXR is reported an important intestinal 
barrier regulator.  And since PXR has a large and flexible binding pocket, it might also 
accommodate various bacterial metabolites[22].  
Since the barrier proteins are involved in the resistance of host cells to the 
bacterial invasion, we are interested in investigating the potential mechanism whereby 
PXR enhances the resistance to bacterial invasion by up-regulating the levels of 
expression of the barrier proteins.  In our study, we investigated the possible mechanism 
that PXR affects the membrane protein expression level like CDC42, RAC1[25], ZO-1 
and occludin[19].  The occludin is a transmembrane protein that establishes homophilic 
interaction between adjacent cells, and ZO-1 is an adaptor at the intracellular surface of 
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tight junctions to link several signaling pathways to actin cytoskeleton.  These 
membrane proteins are the structure proteins specific related to Salmonella infection by 
affecting the stability and permeability of cells, and thus make cells more susceptible to 
Salmonella infection.  So we used realtime PCR to measure the expression of these 
membrane proteins to investigate if there is a regulatory role of PXR in the bacterial 
infection.  
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2. MATERIALS AND METHODS 
2.1 Chemical reagents  
DMEM/High Glucose (HyClone, UT);  Penicillin-streptomycin, phosphate-
buffered saline, fetal bovine serum (Gibco);  Oligonucleotides as the PCR primers (IDT);  
LipofectAMINE (Invitrogen, CA);  Trizol (Ambion, NZ);  Firely luciferase assay kit, 
firely luciferase lysis buffer (Biotium);  All other reagents are from Sigma;  iTaq 
universal SYBR green supermix (Bio-Rad). 
 
2.2 Cell cultural  
The human HepG2 and HT29 cell lines were purchased from American Type 
Culture Collection (ATCC, VA).  Human colon carcinoma cell lines (HCT116, 
HCT116-PXR) were gifts from Dr. Xie (department of pharmacology and chemical 
biology, University of Pittsburg).  Stable PXR transfected cells (PXR-HT29, PXR-
HepG2) were constructed in our laboratory before.  
Human colon carcinoma cells (HT29, HT29-PXR, HCT116, HCT116-PXR), and 
human liver carcinoma cells (HepG2, HepG2-PXR) were cultured in DMEM/high 
glucose with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (P.S).  
Transfected cell HepG2-PXR need G-418 (100 µg/mL) to be specific selected at 37°C in 
5% CO2 atmosphere. 
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2.3 Salmonella infection assay 
Salmonella Typhimurium (gift from Dr. Lawhon, department of veterinary 
pathobiology, Texas A&M University) was inoculated overnight agitated in Luria–
Bertani (LB) solution at 37°C[26], because spectrophotometric results suggested 
overnight culture was enough time for bacteria to obtain mid-log growth phase.  The 
bacterial concentration was around 5x107 CPU/mL, and about 106 bacteria were added to 
each well in 24-well plates. 
Treated cell lines with DMSO, RIF (25 µM), hyperforin (0.2 µM), ketoconazole 
(25 µM) and LPS (1 µg/mL) for 24 h in 24-well plates.  Plates of treated cells were 
inoculated with the Salmonella, centrifuged for 10 min at 1000 rpm and cultured for 30 
min, after extensively washed the plates with phosphate-buffered saline (PBS) for three 
times, 5 min each time, changed the medium to DMEM/High glucose with 100 µg/mL 
gentamicin and cultured for 1 h.  After PBS washing three times, 5 min each time, the 
extracellular bacteria were washed away.  0.1% Triton X-100 in PBS was applied to 
each well, which was then placed on an orbital shaker for 5 min to lyse the cells 
completely.  Made a 104-fold dilution of the lysed cells with PBS and bacteria were 
released on LB plates.  Counted and calculated bacterial colony counts as CFU/mL. 
 
2.4 RNA extraction and reverse transcription 
RNA was extracted by Trizol reagent and reverse transcribed to cDNA by 
reverse kit.  RNA purity and concentration were measured by Nanodrop ND-100 
Spectrophotometer.  The RNA concentration was adjusted to 1000 µg/mL. 
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RT-PCR reaction system was in 20 µL reaction mixtures with 12 µL of random 
primer (10 ng/µL), ran at 80°C for 10 min, and added 2 µL DTT, 2 µL DNTP (10 mM), 
4 µL 5x first-strand buffer and 1 µL MLV enzyme from reverse transcriptase, ran at 
37°C for 2 h.  
 
2.5 Quantitative realtime PCR analysis 
Realtime PCR analysis was conducted with iTaq universal SYBR green supermix 
two-step kit.  The reversed cDNA was amplified and detected using 15 µL reaction 
mixtures with 7.5 µl of iTaq universal SYBR green supermix, 0.75 µL of forward and 
reverse primers (100 nM) respectively, 2 µL of cDNA template, and 4 µL of DEPC 
water.  The detection system ran at 50°C for 10 min, 95°C for 2 min, along with 95°C 
for 10 s and 58°C for 30 s for 35 cycles.  Results from housekeeping gene (β-actin) were 
used for normalization.  
Realtime PCR primers were listed as follows: ZO-1 forward, 5’-
GTGTTGTGGATACCTTGT-3’, and reverse, 5’-GATGATGCCTCGTTCTAC-3’[27];  
Cdc42 forward, 5′-CTTTCTTGCTTGTTGGGACT-3′, and reverse ， 5′-
ACACCTGCGGCTCTTCTT-3′[28];  Occludin forward, 5′-
TCAGGGAATATCCACCTATCACTTCAG-3′, and reverse, 5′-
CATCAGCAGCAGCCATGTACTCTTCAC-3′[29];  Rac1 forward, 5′-
CCCTATCCTATCCGCAAACA-3′, and reverse, 5′-CGCACCTCAGGATACCACTT-
3′[30].  The list of primer sequences and their functions is shown in Table 1. 
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Table 1. Primer sequences and functions in the realtime PCR assay  
Gene Functions Primer sequences 
β-actin Reference gene AGAGCTACGAGCTGCCTGAC 
AGCACTGTGTTGGCGTACAG 
ZO-1 Tight junction protein F: GTGTTGTGGATACCTTGT  
R: GATGATGCCTCGTTCTAC 
Cdc42 Membrane protein F: CTTTCTTGCTTGTTGGGACT  
R: ACACCTGCGGCTCTTCTT 
Occludin Tight junction protein F: TCAGGGAATATCCACCTATCACTTCAG 
R: CATCAGCAGCAGCCATGTACTCTTCAC 
Rac1 Membrane protein F: CCCTATCCTATCCGCAAACA  
R: CGCACCTCAGGATACCACTT 
β-catinine Membrane protein  F: GAACCAGACAGAAAAGCGG 
R: GCTACTTGTTCTTGAGTGAAG 
CYP3A4 PXR regulating gene F: CCACAAAGCTCTGTCCGA TCT  
R: GAACACTGCTCGTGGTTTCACA  
 
2.6 Statistical analysis 
Colony forming unit (CFU) was to measure and calculate viable bacteria or fungi 
counts.  In 1 mL of bacteria solution: 
CFU = No. of colonies x dilution factor                               (1) 
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The results were calculated as mean ± standard deviation (SD) and applied to 
SPSS 20.0 to calculate the p-value.  P values <0.05 and <0.01 were used to indicate 
statistical significance.  All experiments were triplicated to make sure repeatability.
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3. RESULTS 
3.1 PXR stable clones and cell-based assay for determination of PXR agonist and 
antagonist activity   
PXR stable clones were generated by stable transfection of pCI-neo plasmid 
carrying the hPXR cDNA in colon carcinoma cell lines HT29 and HepG2.  The 
transfected cells were selected under the antibiotics neomycin.  In addition, a luciferase 
reporter gene assay was developed where human PXR cDNA was stably co-transfected 
with CYP3A4 gene upstream regulatory regions in HepG2 cells[31].  A stable clone was 
chosen for the analysis of compounds with PXR against and antagonist activity.  The 
known PXR agonists RIF and hyperforin were found to activate the luciferase reporter 
gene and the agonist activity could be antagonized upon co-treatment with PXR 
antagonists ketoconazole and clotrimazole[32] (Figure 7).     
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Figure 7. PXR agonist and antagonist activities determined by PXR-regulated luciferase 
reporter assay 
A cell-based luciferase assay was performed to determine the PXR agonist and antagonist activities.  A. 
PXR-driven luciferase reporter cell was treated with RIF (25 µM), hyperforin (0.2 µM), SJW extract 
(1/1000 from a one gram capsule) and valerian root extract (1/1000 from a one gram capsule) for 24 h.  B. 
The reporter cell line was co-treated with RIF and PXR antagonists ketoconazole (25 µM) or clotrimazole 
(25 µM) for 24 h.  C. The reporter cell line was co-treated with hyperforin and PXR antagonists 
ketoconazole (25 µM) or clotrimazole (25 µM) for 24 h.  
 
PXR agonist and antagonist activities were tested in the PXR-HepG2 cell as 
shown in Figure 7A.  It is aligned to published reports that RIF and hyperforin function 
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as PXR agonists and can induce PXR activity by 5 times.  Additionally some herbal 
medicine can induce PXR activity including SJW and valerian root, but the induced rates 
are less than that of RIF and hyperforin.  The fact that hyperforin is extracted and 
condensed from SJW explains that hyperforin is a more effective PXR agonist than SJW.  
Valerian root is most commonly used to cure sleep disorder, especially insomnia, and 
SJW is commonly used for depression treatment.  Since PXR is discovered in many 
important clinical DDIs, and PXR-mediated drug interactions sometimes lead to ADIs, 
the uses of valerian root and SJW are suggested to avoid co-administered with other 
PXR-targeted drugs.  
Among all PXR antagonists that inhibit PXR transactivation reported until now, 
the most common and investigated are the azole class of chemicals, such as 
ketoconazole and clotrimazole as shown in Figure 7B and 7C. 
 
3.2 PXR regulates the resistance to Salmonella infection in colon cell lines 
We performed the bacterial infection assay with Salmonella in PXR expression 
colon cell lines.  Salmonella in mid-log growth phase were used to inoculate the PXR-
transfected colon cell lines for 30 min and then the cells were cultured with 
DMEM/High glucose with 100 µg/mL gentamicin and cultured for 1 h.  After PBS 
washing three times, 5 min each time, the extracellular bacteria were washed away.  0.1% 
Triton X-100 in PBS was applied into each well, which was then placed on an orbital 
shaker for 5 min to lyse the cells completely.  Made a 104-fold dilution of the lysed cells 
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with PBS and bacteria were released on LB plates.  Counted and calculated bacterial 
colony counts as CFU/mL.   
The colon cells expressing PXR were resistant to Salmonella infection in a 
ligand-dependent manner.  Aligned with the PXR role in regulating the Salmonella 
infection, the PXR-regulated resistance could be antagonized by PXR antagonist 
ketoconazole (Figure 8-10).   
 
 
Figure 8. Salmonella infection assay in PXR-HT29 and HT29 cells 
A is PXR-HT29 transfected cell and B is HT29 cell without PXR.  The cells were pretreated with RIF (25 
µM) and hyperforin (0.2 µM) for 24 h and were incubated with Salmonella for 30 min.  The bacterial 
infectivity was determined by the infection assay.  Antagonizing RIF- or hyperforin-induced PXR activity 
by ketoconazole (25 µM) resulted in increased susceptibility of host cells to bacterial infection.  
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Figure 9. Salmonella infection assay in PXR-HCT116 and HCT116 cells 
A is PXR-HCT116 transfected cell and B is HCT116 cell without PXR.  The cells were pretreated with 
RIF (25 µM) and hyperforin (0.2 µM) for 24 h and were incubated with Salmonella for 30 min.  The 
bacterial infectivity was determined by the infection assay.  Antagonizing RIF- or hyperforin-induced 
PXR activity by ketoconazole (25 µM) resulted in increased susceptibility of host cells to bacterial 
infection. 
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Figure 10. Salmonella infection assay 
A and C are PXR transfected cells and D and F are cells without PXR.  Cells were pretreated with RIF (25 
µM) and hyperforin (0.2 µM) for 24 h and were incubated with Salmonella for 30 min.  The bacterial 
infectivity was determined by the infection assay.  Antagonizing PXR activity by LPS (1 µg/mL) through 
NF-κB pathway resulted in increased susceptibility of host cells to bacterial infection.  The results showed 
RIF- and hyperforin-induced resistance were reversed by LPS treatment. 
 
From Figure 8, 9A, we can see a decreased intercellular CFU count by 2 folds in 
PXR transfected cells but no significant decrease in HT29 and HCT116 cells, suggesting 
that after PXR is activated, there are less Salmonella invaded inside of cells.  It is 
reported that the antagonized role of ketoconazole is functioned when co-treated with 
agonist, as seen in Figure 8, 9B, there are increased intercellular CFU counts in 
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ketoconazole & RIF and ketoconazole & hyperforin groups compared to RIF and 
hyperforin individually in PXR transfected cells, suggesting when PXR activation is 
antagonized by ketoconazole, there are increased Salmonella infection.   
Ketoconazole is clinically used to treat fungal skin infection.  Since ketoconazole 
does not have much antagonize function of PXR activity when working alone, people 
using it to treat fungi infection should not worry about the susceptibility of bacterial 
infection.  
 Interestingly, we found LPS increases Salmonella infection more significantly in 
cells lack of PXR (3 folds) than in PXR transfected cells.  Even after co-treated LPS 
with RIF or hyperforin, intercellular bacteria only reduce slightly in cells lack of PXR in 
contrast with the dramatic decrease in PXR transfected cells (Figure 10).  The 
percentage of the changing CFU is demonstrated in Table 2.  These findings show that 
colon cells without PXR expression are more susceptible to bacterial infection, and 
adding PXR agonist cannot reduce intercellular bacterial counts because not enough 
PXR is activated in PXR deficient cells, which aligns with our earlier study that LPS 
activated NF-κB is mutual repressive with PXR function.  
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Table 2 Percentages of CFU changes in infection assay (%) 
Cell lines RIF Hyper K+RIF 
(RIF) 
K+Hyper 
(Hyper) 
LPS LPS+RIF 
(LPS) 
LPS+Hyper 
(LPS) 
PXR-HT29 32.4 -45.2 39.3 21.4 42.6 -27.5 -56.2 
HT29 14.8 -4.3 27.2 6.0 150 -8.2 -6.8 
PXR-HCT116 40.5 -22.1 54.8 27.3 175 -22.7 -36.1 
HCT116 -19 -6.3 25.5 5.1 227 -3.3 -12.6 
*Hyper: Hyperforin 
 
3.3 Determination of the role of occludin in Salmonella infection by realtime PXR 
Salmonella is a strong invasive pathogen that invades host cells by disrupting the 
host cell epithelial structure and dissociating tight junction proteins[19], among which, 
occludin is a transmembrane protein that establishes homophilic interaction between 
adjacent cells.  Report showed occludin was decreased in Salmonella infection[19], 
suggesting occludin is involved in the Salmonella invasion process.  We tested several 
important tight junction proteins such as occludin, ZO-1, and claudin, and found PXR 
acts as a regulatory role in up-regulating the expression of occludin.  Figure 11 shows 
the expression of occludin at the mRNA level.  Figure 12 shows the regulatory role of 
PXR in tight junction. 
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Figure 11. PXR activation results in increases in expression of barrier protein occludin 
PXR-enhanced and parental cells were pretreated with agonists by RIF (25 µM) and hyperforin (0.2 µM) 
for 24 h, and treated cells were inoculated with bacteria for 30 min.  Total RNA were extracted from the 
cells for realtime-PCR determination of the occludin mRNA level.   
 
 
Figure 12. The regulatory role of PXR in tight junction 
 
Occludin is a transmembrane protein that establishes homophilic interaction 
between adjacent cells.  It is reported in Salmonella infection, the expression of occludin 
is decreased after bacteria invasion[19].  And our results shows that activated PXR can 
induce the expression of occludin in PXR transfected cells, but in cells without PXR, 
occludin expression does not change or even decrease, which aligns with our previous 
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study that RIF and hyperforin are harmful to cells when without PXR.  The results show 
that PXR decreases intercellular bacterial counts by regulating the expression of 
occludin, which is involved in Salmonella invasion.  Since PXR is mainly deposited in 
epithelial cells, it is logical that activated epithelial PXR is responsible for regulating 
intestinal barrier as we observed.  
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4. CONCLUSIONS 
 
The PXR was initially identified and characterized as the xenobiotic sensor and 
effector[33] responsible for metabolism of various prescription drugs and xenobiotics.  
PXR together with other xenobiotic receptors such as AhR, CAR and FXR form a 
chemical defense network guarding the body against the xenobiotic insults[15] including 
mutagenic DNA damages induced by BaP[11].  Consistent with its role as the master 
xenobiotic receptor, it is highly expressed in the liver and other parts of the GI tract.  
PXR has been found to interact with other transcription factors such as the NF-κB[31] and 
this crosstalk has been found to be an important pivot for mutual regulation between the 
receptor-regulated pathway and NF-κB regulated immune/inflammatory pathway.  The 
interactions between PXR and NF-κB have been found to be important for the 
maintenance of the homeostasis of GI tract as the PXR null mice demonstrated 
spontaneous intestinal inflammation[7].  Clearly, the complexity of the GI tract 
microbiota with their metabolites harbor enormous potentials for mediating the 
interactions between microbiota and host cells, and PXR with its wide range of ligand 
specificity is likely to play a critical role in regulating the host-microbiota interaction as 
demonstrated in several recent studies[7].  To understand the role of PXR in regulating 
the interactions between pathogen and host GI tract, we analyzed the effects of PXR on 
the invasion of Salmonella in colon cell lines transfected with PXR.  
 Many cancer cell lines from the GI tract such as HepG2 and HT29 have reduced 
the level of PXR expression, and the reduced PXR expression has been suggested as part 
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of the pathogenesis.  Indeed, it has been shown the pediatric Chron’s disease is 
associated with the reduced PXR expression, and in mice activation of PXR has been 
found to reduced inflammation and inhibited tumorigenesis[34, 35].  One of the 
underpinning mechanisms for the diseases is postulated to be the crosstalk between PXR 
and NF-κB. 
Results from recent studies have revealed novel functions of PXR in regulating 
the various physiological functions including the immune responses, lipid and glucose 
levels, and homeostasis of GI tract through its ability to interact with the natural 
metabolites from the intestinal microbiota[7].  Recently, accumulating results suggest that 
deficiency in PXR are linked with the inflammation in the GI tract[36].  However, the 
mechanisms involved in the protective functions are likely to be multiple dimensions, 
one of which is its role in regulation of immunity against bacterial infection.  The 
interactions between commensal microbiota and intestinal epithelium are important for 
the homeostasis of the GI tract and of particular interest is a recent report indicating that 
symbiotic bacterial metabolites regulate gastrointestinal barrier function via the 
xenobiotic sensor PXR, one may surmise PXR may play a role in guarding the GI 
epithelium against the invasion of the pathogenic bacteria.  We utilized human colon cell 
lines with transfected PXR to analyze the potential role of PXR in protecting the cells 
from Salmonella invasion and also investigated the role of PXR in regulating the 
expression of the barrier genes such as occludin, a transmembrane protein located at 
tight junction.  Our results strongly suggest that PXR plays a pivotal role in the 
epithelium against the bacterial invasion.  
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 In summary, PXR shows a protective role to resist Salmonella infection in PXR 
transfected cells.  One mechanism is by regulating the expression of a tight junction 
protein-occludin.  
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